ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Lorati Unveils Nano-Emulsion: A Breakthrough Natural Therapy for Stroke Recovery

A Breakthrough Natural Therapy for Stroke Recovery

TAICHUNG, TAIWAN, July 14, 2025 /24-7PressRelease/ -- Lorati Co., Ltd., a pioneer in nano-grade biomedical innovation, proudly announces a major medical breakthrough: Lorati Nano-Emulsion, a 100% natural, mineral-based emulsion developed to support full recovery for both hemorrhagic and ischemic stroke patients.

Unlike conventional treatments, Lorati Nano-Emulsion offers a non-invasive, at-home therapy. Patients consume between 1,600 to 2,000 cc daily, with recovery timelines ranging from 12 to 30 months, depending on stroke type, blood pressure condition, and other underlying health issues.

The Science Behind the Cure
Effective stroke recovery requires:
• Complete clearance of blood clots (aneurysms) and foam cells
• Restoration of elasticity in stiffened blood vessels
• Elimination of inhibitory molecules such as AGEs (Advanced Glycation End-products), ALEs (Advanced Lipoxidation End-products), and excessive heavy metals

By cleansing the body of these inhibitory factors, endogenous stem cells can be activated to regenerate damaged brain tissue through differentiation, dedifferentiation, and proliferation.

Mr. David Lo, CEO of Lorati, explains that true stem cell therapy lies in restoring the body's own regenerative ability—not through autologous or allogeneic stem cell transplants, which are fundamentally flawed.

Historic Success: Brain Stem Stroke Recovery
A recent case involving a patient with central pontine hemorrhagic stroke—one of the most severe types of brainstem stroke—has been fully cured after 30 months of nano-emulsion therapy. This unprecedented outcome has stunned medical experts, including professors at National Taiwan University. It marks the first recorded instance in human history of a complete recovery from this type of stroke.

Mr. Lo further explains that if brainstem hemorrhagic strokes can be cured with Lorati's Nano-emulsion, other forms of stroke may also be curable with the same therapy.

About Lorati Co., Ltd.
Founded in 2012 in Taichung, Taiwan, Lorati Co., Ltd. is a global leader in nano-grade mineral-based medicine. Through proprietary extraction and refinement of montmorillonite—referred to as "God's extract of clay"—the company produces advanced, all-natural therapies designed to regenerate tissue and support healing without side effects. Lorati's innovative solutions, including its flagship nano-grade eye drops for age-related macular degeneration, have earned international recognition for their safety, purity, and effectiveness.

For inquiries or further information, please contact Lorati's service team.
Email: service@lorati.com.tw
Tel: +886 4 2483 5965
Website: https://www.lorati.com.tw



---
Press release service and press release distribution provided by https://www.24-7pressrelease.com
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.